CANCER EARLY DETECTION BLOOD TEST – hPG80
AED2,200
The hPG80 blood test is designed for individuals at high risk of developing cancer. Elevated hPG80 levels are often associated with cancer cell activity, and this test can help everyone monitor health and detect cancer at an early stage. With early detection, cancer patients can start treatment early and increase the chances of a successful outcome.
Description
At BALSAM, we understand that cancer prevention and early detection are critical for better health outcomes.
We offer the hPG80 blood test, a diagnostic tool for early cancer suspicion, stage monitoring, treatment assistance, and relapse detection.
hPG80 Test Overview
An exclusive service provided by the Preventive Health and Research Unit at Balsam
- A universal blood-based tumor marker.
- Simple and hassle-free blood test.
- Saves life, time, and money through early detection and treatment.
- Patients can avoid radiation exposure and repeat the test routinely, as needed.
- Detects patients likely to have cancer, in a population at risk, even before stage 1.
- hPG80 has been detected in all stages of cancer patients, with the same high accuracy, from stage I to stage IV.
- The average rate of accuracy is 83% amongst all types.
- hGP80 has been detected in cancers with no known tumor makers to date.
- Developed by Biodena Care in France; EU Board Approved and CE-IVD.
- hPG80 detects cancer activity of more than 16 types of cancer, such as:
Brain tumors, all cancers of the Head and Neck, Skin, Lung, Liver, Pancreatic, Stomach, Colon, Rectal, Prostate, Uterine, Cervical, Neuroendocrine tumors, Ovarian, Kidney, and Breast cancer.
Contact us today to learn more about this test and how it can help you stay on top of your health.
